sickle cell disease

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:Genetics
gptkbp:affects red blood cells
gptkbp:associated_with sickle cell trait
gptkbp:caused_by mutation in HBB gene
gptkbp:clinical_trial ongoing for new treatments
exploring new drug therapies
investigating gene editing techniques
studying pain management strategies
testing stem cell therapies
gptkbp:community_impact affects millions worldwide
significant health burden in endemic regions
gptkbp:community_support gptkb:fundraising_events
advocacy initiatives
educational workshops
awareness campaigns
patient support groups
gptkbp:complication stroke
pulmonary hypertension
organ damage
acute chest syndrome
gptkbp:cultural_impact influences music and art
promotes research funding
raises awareness in communities
gptkbp:diagnosis newborn screening
hemoglobin electrophoresis
gptkbp:educational_resources gptkb:healthcare_professionals
community outreach programs
patient advocacy groups
gptkbp:historical_context associated with malaria resistance
first described in 1910
https://www.w3.org/2000/01/rdf-schema#label sickle cell disease
gptkbp:inherits_from autosomal recessive
gptkbp:is_involved_in gptkb:Sickle_Cell_Society
gptkb:Sickle_Cell_Disease_Association_of_America
gptkb:Sickle_Cell_Foundation
gptkbp:lifespan reduced compared to general population
gptkbp:prevalence more common in African descent
more common in Mediterranean descent
more common in Middle Eastern descent
gptkbp:public_awareness September
gptkbp:research_focus gptkb:gene_therapy
new medications
pain management
gptkbp:symptoms gptkb:anemia
frequent infections
pain crises
swelling in hands and feet
gptkbp:treatment bone marrow transplant
hydroxyurea
blood transfusions
gptkbp:bfsParent gptkb:Sangamo_Therapeutics
gptkb:Vertex_Pharmaceuticals
gptkb:St._Jude_Children's_Research_Hospital
gptkb:CRISPR-Cas9
gptkb:CRISPR_technology
gptkbp:bfsLayer 4